A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Daclatasvir | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052; EBP 883. CAS No. 1009119-64-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10466. |  |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grade: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. |  |
| Daclatasvir-d16 | Daclatasvir-d16 is a labelled Daclatasvir which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: BMS-790052-d16; EBP 883-d16. Grade: > 95%. Molecular formula: C40H34D16N8O6. Mole weight: 754.97. | |
| Daclatasvir-d6 | Daclatasvir-[d6], is the labelled analogue of Daclatasvir. Daclatasvir, inhibits the HCV protein NS5A, and can be used in combination with other medications to treat hepatitis C (HCV). Synonyms: 1801709-41-0; Daclatasvir-d6; Melphalan Dimer-d8 Dihydrochloride; MelphalanDimer-d8Dihydrochloride; trideuteriomethyl N-[(2S)-3-methyl-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-3-methyl-2-(trideuteriomethoxycarbonylamino)butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate; Daclatasvir SRRS Isomer-d6; DA-62636. Grade: > 95%. CAS No. 1801709-41-0. Molecular formula: C40H44D6N8O6. Mole weight: 744.91. | |
| Daclatasvir Diethyl Ester-d10 | Daclatasvir Diethyl Ester-d10 is the isotope labelled analog of Daclatasvir Diethyl Ester (D101525); an impurity of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H44D10N8O6, Molecular Weight: 776.99. US Biological Life Sciences. |  Worldwide |
| Daclatasvir dihydrochloride | Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052 dihydrochloride; EBP 883 dihydrochloride. CAS No. 1009119-65-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10465. | |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grade: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6·2HCl. Mole weight: 811.8. | |
| Daclatasvir Impurity 10 | Daclatasvir Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009119-83-8. Molecular formula: C26H29ClN6. Mole weight: 461.01. Catalog: APB1009119838. |  |
| Daclatasvir Impurity 11 | Daclatasvir Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007882-23-6. Molecular formula: C36H44N6O4. Mole weight: 624.79. Catalog: APB1007882236. | |
| Daclatasvir Impurity 1 (RSSS-Isomer) | Daclatasvir Impurity 1 (RSSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: dimethyl ((2S,2'R)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1417333835. | |
| Daclatasvir Impurity 1 (SRSS-Isomer) | Daclatasvir Impurity 1 (SRSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Daclatasvir Impurity 1 (SRSS-Isomer). CAS No. 1009117-28-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1009117285. | |
| Daclatasvir Impurity 4 | Daclatasvir Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009117263. | |
| Daclatasvir Impurity 5 | Daclatasvir Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009107270. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007884-60-7. Molecular formula: C33H39N7O3. Mole weight: 581.72. Catalog: APB1007884607. | |
| Daclatasvir RSSR Isomer | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir Impurity 4; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir RSSS Isomer | Daclatasvir RSSS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester stereoisomer. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Daclizumab | Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. | |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm) [1]. Uses: Scientific research. Group: Fluorescent dye. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| DACM | DACM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N-(7-Dimethylamino-4-methylcoumarin-3-yl)maleimide. Product Category: Other Fluorophores. Appearance: Orange solid. CAS No. 55145-14-7. Molecular formula: C16H14N2O4. Mole weight: 298.29. Purity: 98%+. IUPACName: 1-[7-(dimethylamino)-4-methyl-2-oxochromen-3-yl]pyrrole-2,5-dione. Canonical SMILES: CC1=C(C(=O)OC2=C1C=CC(=C2)N(C)C)N3C(=O)C=CC3=O. Product ID: ACM55145147-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide, Dachshund. |  |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC 50 s of 6 nM, 45.7 nM and 73.7 nM for EGFR , ERBB2 , and ERBB4 , respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib hydrate | Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan- ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804 hydrate; PF-299804 hydrate. CAS No. 1042385-75-0. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-118263. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13991-36-1. Molecular formula: C4H5BrO2. Mole weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grade: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity SF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25F2N5O2. Mole weight: 453.49. | |
| Dacomitinib Impurity SFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: Dacomitinib Impurity SFAJ; CS-0255393; F83329; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine; N4-(3,4-DIFLUOROPHENYL)-7-METHOXY-QUINAZOLINE-4,6-DIAMINE; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity). Grade: ≥95%. CAS No. 2117703-26-9. Molecular formula: C15H12F2N4O. Mole weight: 302.28. | |
| Dacomitinib Impurity SFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 2119689-75-5. Molecular formula: C15H10F2N4O3. Mole weight: 332.26. | |
| Dacomitinib Impurity SL | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25Cl2N5O2. Mole weight: 486.40. | |
| Dacomitinib Impurity SLAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12Cl2N4O. Mole weight: 335.19. | |
| Dacomitinib Impurity SLXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10Cl2N4O3. Mole weight: 365.17. | |
| Dacomitinib Impurity WZYG | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity WZYGAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.74. | |
| Dacomitinib Impurity WZYGXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacotinib Monohydrate | Dacotinib Monohydrate. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide hydrate. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2·H2O. Mole weight: : 487.95. Catalog: APB1042385750. | |
| Dacthal monoacid | Dacthal monoacid. Group: Biochemicals. Alternative Names: 2,3,5,6-Tetrachloro-1,4-benzenedicarboxylic acid 4-methyl ester. Grades: Highly Purified. CAS No. 887-54-7. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C9H4Cl4O4. US Biological Life Sciences. | Worldwide |
| DACT-II | DACT-II. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 9-(4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine. Product Category: Organic Light Emitting Diode (OLED). CAS No. 1613074-59-1. Molecular formula: C57H40N6. Mole weight: 808.97 g/mol. Product ID: ACM1613074591-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: Dactinomycin. | |
| Dactimicin | Dactimicin is an aminoglycoside antibiotic produced by Dactilosporangium matsuzakiense SF-2O52. It has anti-gram-positive and negative bacteria activity. Synonyms: SF-2052. Grade: >98%. CAS No. 73196-97-1. Molecular formula: C18H36N6O6. Mole weight: 432.51. | |
| Dactimicin sulfate | Dactimicin sulfate is an aminoglycoside antibiotic produced by Dactilosporangium matsuzakiense SF-2O52. It has anti-gram-positive and negative bacteria activity. Synonyms: Antibiotic SF 2052 sulfate; L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N-methylacetamido)-, sulfate (1:2), hydrate. Grade: >98%. CAS No. 73245-91-7. Molecular formula: C18H40N6O14S2. Mole weight: 628.67. | |
| Dactolisib | Dactolisib (BEZ235) is an orally active and dual pan-class I PI3K and mTOR kinase inhibitor with IC50s of 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110?/p110?/p110?/p110? and mTOR, respectively. Dactolisib (BEZ235) inhibits both mTORC1 and mTORC2. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BEZ235; NVP-BEZ235. CAS No. 915019-65-7. Pack Sizes: 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-50673. | |
| Dactolisib | Dactolisib, also known as BEZ235, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BEZ235 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability. Synonyms: BEZ235; BEZ-235; BEZ 235; NVPBEZ235; NVP-BEZ235; NVP-BEZ-235; NVP-BEZ 235; Dactolisib. Grade: 0.98. CAS No. 915019-65-7. Molecular formula: C30H23N5O. Mole weight: 469.548. | |
| Dactylarin | Dactylarin is an antibiotic produced by Dactylaria lutea. It has strong anti-Leishmania and Enterobacter activity, anti-Gram-positive bacteria activity, but no anti-negative bacteria, yeast and mold activity. Synonyms: Altersolanol B. Grade: >98%. CAS No. 22350-90-9. Molecular formula: C16H16O6. Mole weight: 304.29. | |
| Dactylfungin A | Dactylfungin is an antifungal antibiotic produced by Dactylaria parvispora D500 and separates the two components A and B. A and B have no antibacterial activity. Synonyms: 2H-Pyran-2-one, 3-(4-deoxy-beta-xylo-hexopyranosyl)-4-hydroxy-6-(2-hydroxy-7-(hydroxymethyl)-1,1,5,9,11,13,17,19-octamethyl-3,5,13,15,17-heneicosapentaenyl)-. CAS No. 146935-35-5. Molecular formula: C41H64O9. Mole weight: 700.94. | |
| Dactylfungin B | Dactylfungin is an antifungal antibiotic produced by Dactylaria parvispora D500, and two components A and B are separated. A and B have no antibacterial activity. B is resistant to individual Candida and Saccharomyces fungi (MIC 3.1-6.2 μg/mL), and has a weak effect on important pathogenic fungi such as Candida albicans (MIC >100μg/mL). Synonyms: 4H-Pyran-4-one, 3-(4-deoxy-beta-xylo-hexopyranosyl)-2-hydroxy-6-(2-hydroxy-7-(hydroxymethyl)-1,1,5,9,11,13,17,19-octamethyl-3,5,13,15,17-heneicosapentaenyl)-. CAS No. 146935-36-6. Molecular formula: C41H64O9. Mole weight: 700.94. | |
| Dactylocycline A | Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp. Dactylocycline A has anti-Gram-positive bacteria and weak anti-Gram-negative bacteria activity, and is not cross-resistant with tetracycline-resistant bacteria. Synonyms: 7-chloro-4-(dimethylamino)-3,4a,10,12,12a-pentahydroxy-6-((4-(hydroxyamino)-5-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-8-methoxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide. CAS No. 125622-12-0. Molecular formula: C31H40ClN3O13. Mole weight: 698.11. | |
| Dactylocycline B | Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp. Dactylocycline B has anti-Gram-positive bacteria and weak anti-Gram-negative bacteria activity, and is not cross-resistant with tetracycline-resistant bacteria. Synonyms: 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-6-((2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-alpha-L-arabino-hexopyranosyl)oxy)-, (4R-(4alpha,4aalpha,5aalpha,6alpha,12aalpha))-; 7-chloro-4-(dimethylamino)-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-((5-methoxy-4,6-dimethyl-4-nitrotetrahydro-2H-pyran-2-yl)oxy)-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide. CAS No. 125622-13-1. Molecular formula: C31H38ClN3O14. Mole weight: 712.10. | |
| Dactylocycline D | Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp. Dactylocycline D has anti-Gram-positive bacteria activity. Synonyms: 6-((4-(acetoxyamino)-5-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-chloro-4-(dimethylamino)-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide. CAS No. 146064-00-8. Molecular formula: C33H42ClN3O14. Mole weight: 740.15. | |
| Dactylocycline E | Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp. Dactylocycline E has anti-Gram-positive bacteria activity. CAS No. 146064-01-9. Molecular formula: C31H39ClN2O13. Mole weight: 683.11. | |
| Dactylorhin A | Dactylorhin A, a succinate derivative ester, is isolated from rhizomes of Gymnadenia conopsea. Dactylorhin A exhibits moderate inhibitory effects on NO production effects in RAW 264.7 macrophage cells [1] [2]. Uses: Scientific research. Group: Natural products. CAS No. 256459-34-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-125531. | |
| dactylysin | An endopeptidase of 100 kDa secreted from the skin of the amphibian, Xenopus laevis (Dactylêtre du Cap). Resembles neprilysin in insensitivity to 1 μM captopril, but differs from it in being insensitive to thiorphan (1 μM) and unable to digest [Met5]enkephalin, [Leu5]enkephalin, oxytocin, and substance P-(7-11)-peptide. A similar endopeptidase is found in human neuroblastoma cells. Group: Enzymes. Synonyms: peptide hormone inactivating endopeptidase; PHIE. Enzyme Commission Number: EC 3.4.24.60. CAS No. 139466-40-3. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4343; dactylysin; EC 3.4.24.60; 139466-40-3; peptide hormone inactivating endopeptidase; PHIE. Cat No: EXWM-4343. |  |
| DAD | DAD is a type of ion channel blocker. It blocks voltage-gated potassium channels. DAD has the potential for restoring visual function. Molecular formula: C26H40N6O. Mole weight: 452.64. | |
| DAD dichloride | DAD dichloride is a type of ion channel blocker. It blocks voltage-gated potassium channels. DAD dichloride has the potential for restoring visual function. Molecular formula: C26H42Cl2N6O. Mole weight: 525.56. | |
| D-Adenosine | 100g Pack Size. Group: Biochemicals. Formula: C10H13N5O4. CAS No. 58-61-7. Prepack ID 20213653-100g. Molecular Weight 267.25. See USA prepack pricing. |  |
| D-Adenosine | 25g Pack Size. Group: Biochemicals. Formula: C10H13N5O4. CAS No. 58-61-7. Prepack ID 20213653-25g. Molecular Weight 267.25. See USA prepack pricing. | |
| DADLE | DADLE is a prototypical δ-opioid receptor agonist with antinociceptive activity. It also exhibits activity at the μ-opioid receptor. Synonyms: [D-Ala2,D-Leu5]-Enkephalin. Grade: >95%. CAS No. 63631-40-3. Molecular formula: C29H39N5O7. Mole weight: 569.65. | |
| DADLE | DADLE. Group: Biochemicals. Grades: Purified. CAS No. 63631-40-3. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| dADPαS | dADPαS is an extraordinary compound, deftly inhibiting key enzymes responsible for DNA replication and repair processes. dADPαS can used to present a promising avenue for suppressing tumor progression. Synonyms: 2'-Deoxyadenosine-5'-(α-thio)-diphosphate, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C10H15N5O8P2S (free acid). Mole weight: 427.26 (free acid). | |
| DAF-2 | DAF-2. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4,5-Diaminofluorescein,5,6-Diaminofluorescein. Product Category: Fluorescein Fluorophores. Appearance: Light yellow powder. CAS No. 205391-01-1. Molecular formula: C20H14N2O5. Mole weight: 362.34. Purity: 95%+. IUPACName: 5,6-diamino-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one. Product ID: ACM205391011-1. Alfa Chemistry ISO 9001:2015 Certified. | |
Our database is helping our users find suppliers everyday.
